Filing Details
- Accession Number:
- 0000014272-17-000173
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-09-08 16:31:09
- Reporting Period:
- 2017-09-06
- Accepted Time:
- 2017-09-08 16:31:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 14272 | Bristol Myers Squibb Co | BMY | Pharmaceutical Preparations (2834) | 220790350 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1341069 | C Joseph Caldarella | Bristol-Myers Squibb Company 345 Park Avenue New York NY 10154 | Svp & Controller | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.10 Par Value | Disposition | 2017-09-06 | 9,340 | $60.00 | 46,297 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock, $0.10 Par Value | 1,779 | Indirect | By BMY Savings and Investment Program |
Footnotes
- Based on a plan statement as of the end of the most recent fiscal quarter
Billionaire Hedge Funds
